<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>OncoBayes2 — OncoBayes2 • OncoBayes2</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="OncoBayes2 — OncoBayes2"><meta name="description" content="Bayesian logistic regression model with optional
EXchangeability-NonEXchangeability parameter modelling for flexible
borrowing from historical or concurrent data-sources. The safety
model can guide dose-escalation decisions for adaptive Oncology
phase I dose-escalation trials which involve an arbitrary number of
drugs."><meta property="og:description" content="Bayesian logistic regression model with optional
EXchangeability-NonEXchangeability parameter modelling for flexible
borrowing from historical or concurrent data-sources. The safety
model can guide dose-escalation decisions for adaptive Oncology
phase I dose-escalation trials which involve an arbitrary number of
drugs."><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/katex.min.css" integrity="sha384-nB0miv6/jRmo5UMMR1wu3Gz6NLsoTkbqJghGIsx//Rlm+ZU03BU6SQNC66uf4l5+" crossorigin="anonymous"><script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/katex.min.js" integrity="sha384-7zkQWkzuo3B5mTepMUcHkMB5jZaolc2xDwL6VFqjFALcbeS9Ggm/Yr2r3Dy4lfFg" crossorigin="anonymous"></script><script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/contrib/auto-render.min.js" integrity="sha384-43gviWU0YVjaDtb/GhzOouOXtZMP/7XUzwPTstBeZFe/+rCMvRwr4yROQP43s0Xk" crossorigin="anonymous" onload="renderMathInElement(document.body);"></script></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">OncoBayes2</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.9-4</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/introduction.html">Guiding Oncology Dose-Escalation Trials</a></li>
    <li><a class="dropdown-item" href="../articles/map_approach.html">Meta-Analytic-Predictive (MAP) approach for dose-toxicity modelling</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/Novartis/OncoBayes2/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>OncoBayes2</h1>
      <small class="dont-index">Source: <a href="https://github.com/Novartis/OncoBayes2/blob/main/R/OncoBayes2-package.R" class="external-link"><code>R/OncoBayes2-package.R</code></a></small>
      <div class="d-none name"><code>OncoBayes2.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Bayesian logistic regression model with optional
EXchangeability-NonEXchangeability parameter modelling for flexible
borrowing from historical or concurrent data-sources. The safety
model can guide dose-escalation decisions for adaptive Oncology
phase I dose-escalation trials which involve an arbitrary number of
drugs.</p>
    </div>


    <div class="section level2">
    <h2 id="global-options">Global Options<a class="anchor" aria-label="anchor" href="#global-options"></a></h2>



<table class="table table"><tr><td>Option</td><td>Default</td><td>Description</td></tr><tr><td><code>OncoBayes2.MC.warmup</code></td><td>1000</td><td>MCMC warmup iterations</td></tr><tr><td><code>OncoBayes2.MC.iter</code></td><td>2000</td><td>total MCMC iterations</td></tr><tr><td><code>OncoBayes2.MC.save_warmup</code></td><td>TRUE</td><td>save warmup samples</td></tr><tr><td><code>OncoBayes2.MC.chains</code></td><td>4</td><td>MCMC chains</td></tr><tr><td><code>OncoBayes2.MC.thin</code></td><td>1</td><td>MCMC thinning</td></tr><tr><td><code>OncoBayes2.MC.control</code></td><td><code>list(adapt_delta=0.99,</code></td><td>sets <code>control</code> argument for Stan call</td></tr><tr><td></td><td><code>stepsize=0.1</code>)</td><td></td></tr><tr><td><code>OncoBayes2.MC.backend</code></td><td>rstan</td><td>Backend used to run Stan (<code>rstan</code> or <code>cmdstanr</code>)</td></tr><tr><td><code>OncoBayes2.abbreviate.min</code></td><td>0</td><td>Minimal length of variable names</td></tr><tr><td></td><td></td><td>when abbreviating variable names.</td></tr><tr><td></td><td></td><td>The default 0 disables abbreviation.</td></tr></table></div>
    <div class="section level2">
    <h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a></h2>
    <p>Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H.
(2016). On the use of co-data in clinical trials. <em>Statistics in
Biopharmaceutical Research</em>, 8(3), 345-354.</p>
<p>Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp;
Bailey, S. (2016). Robust exchangeability designs for early phase
clinical trials with multiple strata. <em>Pharmaceutical
statistics</em>, 15(2), 123-134.</p>
<p>Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008).
Critical aspects of the Bayesian approach to phase I cancer trials.
<em>Statistics in medicine</em>, 27(13), 2420-2439.</p>
<p>Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S.,
Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to
Phase I Combination Trials in Oncology. In <em>Statistical methods
in drug combination studies</em> (Vol. 69). CRC Press.</p>
<p>Stan Development Team (2024). RStan: the R interface to Stan. R package version 2.32.6. https://mc-stan.org</p>
    </div>
    <div class="section level2">
    <h2 id="see-also">See also<a class="anchor" aria-label="anchor" href="#see-also"></a></h2>
    <div class="dont-index"><p>Useful links:</p><ul><li><p><a href="https://opensource.nibr.com/OncoBayes2/" class="external-link">https://opensource.nibr.com/OncoBayes2/</a></p></li>
<li><p>Report bugs at <a href="https://github.com/Novartis/OncoBayes2/issues" class="external-link">https://github.com/Novartis/OncoBayes2/issues</a></p></li>
</ul></div>
    </div>
    <div class="section level2">
    <h2 id="author">Author<a class="anchor" aria-label="anchor" href="#author"></a></h2>
    <p><strong>Maintainer</strong>: Sebastian Weber <a href="mailto:sebastian.weber@novartis.com">sebastian.weber@novartis.com</a></p>
<p>Authors:</p><ul><li><p>Lukas A. Widmer <a href="mailto:lukas_andreas.widmer@novartis.com">lukas_andreas.widmer@novartis.com</a></p></li>
<li><p>Andrew Bean <a href="mailto:andrew.bean@novartis.com">andrew.bean@novartis.com</a></p></li>
</ul><p>Other contributors:</p><ul><li><p>Novartis Pharma AG [copyright holder]</p></li>
<li><p>Trustees of Columbia University (R/stanmodels.R, configure, configure.win) [copyright holder]</p></li>
</ul></div>

  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Sebastian Weber, Lukas A. Widmer, Andrew Bean.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

